BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/3/2025 7:37:37 AM | Browse: 15 | Download: 0
Category |
Endocrinology & Metabolism |
Manuscript Type |
Meta-Analysis |
Article Title |
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Raisa A Aringazina, Afshin Zare, Seyyed Mojtaba Mousavi, Nurgul Abenova, Nadiar Maratovich Mussin and Amin Tamadon |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Clinical Variants of Metabolic Syndrome and Hormonal Mechanisms of its Formation in the Residents of Aktobe City |
8/5-1-04/1-36/1 |
|
Corresponding Author |
Amin Tamadon, Full Professor, PhD, Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, No. 60 Maresiev Street, Aktobe 030012, Kazakhstan. amintamaddon@yahoo.com |
Key Words |
Type 2 diabetes mellitus; Metabolic disorders; Obesity; Insulin lessen; Insulin resistance; Cell therapy; Mesenchymal stem cell |
Core Tip |
This comprehensive review explores the potential of mesenchymal stem cell (MSC)-based therapies, both autologous and allogeneic, for treating type 2 diabetes mellitus. The study evaluates the safety, efficacy, and therapeutic benefits of MSCs, highlighting improvements in glycemic control, reductions in insulin requirements, and enhanced β-cell function. While MSC-based therapies show promising results with minimal adverse effects, challenges remain in standardizing treatment protocols. Future research should aim to refine these therapies and assess their long-term effects through large-scale clinical trials. |
Citation |
Raisa A Aringazina, Afshin Zare, Seyyed Mojtaba Mousavi, Nurgul Abenova, Nadiar Maratovich Mussin, Amin Tamadon. Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis. World J Stem Cells 2025; In press |
 |
Received |
|
2025-04-08 13:19 |
 |
Peer-Review Started |
|
2025-04-08 13:19 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-23 11:47 |
 |
Revised |
|
2025-05-01 06:11 |
 |
Second Decision |
|
2025-06-26 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-07-03 07:37 |
 |
Articles in Press |
|
2025-07-03 07:37 |
 |
Publication Fee Transferred |
|
2025-05-08 05:55 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345